Current trader consensus assigns just a 7-8% chance of a new WHO-designated COVID variant of concern emerging before 2027, driven by the absence of any SARS-CoV-2 lineages meeting VOC criteria for meaningfully higher transmissibility, severity, or immune escape as of mid-2026. ECDC and WHO tracking list only variants of interest or under monitoring, such as certain Omicron sublineages including BA.2.86 and XFG, which show limited prevalence and no major effects on hospitalizations. Ongoing genomic surveillance reveals steady circulation of existing strains without the rapid, high-impact shifts seen in earlier pandemic waves, while widespread immunity from prior infections and updated vaccines continues to limit severe outcomes. With roughly five months remaining, the lack of fresh signals of concern reinforces the strong probability assigned to no new designation.